ShippedBrief
SFDA authorizes Dental IQ and SAARIA AI diagnostic software
Two Saudi-developed medical software products receive marketing authorization for dental and ophthalmic diagnosis support.
SFDA grants authorization for two AI diagnostic tools#
The Saudi Food and Drug Authority granted marketing authorization on September 10, 2026 for two locally developed AI-enabled medical software products: Dental IQ for dental diagnosis and SAARIA for ophthalmic screening. The authorization followed a regulatory review that included assessment of technical documentation and clinical evidence to verify safety, performance and effectiveness. Both products were developed by Saudi startups specializing in AI-driven digital health solutions.
Dental IQ analyzes X-ray images for pathological findings#
Dental IQ utilizes deep learning algorithms to analyze dental X-ray images and support identification of potential pathological findings, including dental caries, periodontal disease and structural changes affecting teeth and supporting tissues. The software is designed as a clinical support tool to help healthcare practitioners improve diagnostic accuracy and inform treatment planning. The company enrolled in the SFDA's Innovative Medical Devices Pathway and conducted local clinical studies in Saudi Arabia to validate the software's performance.
SAARIA screens diabetic patients for retinopathy#
SAARIA utilizes AI technologies to analyze retinal fundus images to support screening of diabetic patients and early detection of diabetic retinopathy in healthcare settings. The software supports identification of patients who may require further specialized ophthalmic evaluation, facilitating timely referral and interventions. The developer committed to post-marketing clinical follow-up plans to monitor real-world performance and ensure continued safe use.
Authorization requires clinical validation and ongoing monitoring#
Both companies fulfilled applicable regulatory requirements, including conducting local clinical studies to validate software performance in Saudi healthcare settings. The SFDA stated that outputs from AI-enabled medical software are intended to support clinical decision-making and do not replace healthcare professional clinical judgment. Healthcare professionals remain responsible for reviewing and validating outputs and making appropriate clinical decisions based on patient condition.
Sources1 source across 1 domain
- saudigazette.com.saSaudi GazetteSFDA granted marketing authorization for Dental IQ and SAARIA on September 10, 2026, following regulatory review including technical documentation and clinical evidence assessment
Each source above carries the claim it supports. Links open the publisher's own page; their text is not reproduced here beyond what the claim requires, and their rights remain theirs.
Startup Arabia is published by Arabian Media Network. Pieces are produced by the Shipped Desk with AI-assisted synthesis of the cited sources and automated verification against the network's editorial policy. Every piece carries a desk rather than a reporter. Corrections are recorded on the piece and on the corrections page.